Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Apr;47(4):714-719.
doi: 10.1002/cbin.11991. Epub 2023 Jan 30.

Human umbilical cord mesenchymal stem cells: Heralding an effective treatment against esophageal cancer?

Affiliations
Review

Human umbilical cord mesenchymal stem cells: Heralding an effective treatment against esophageal cancer?

Reza ArefNezhad et al. Cell Biol Int. 2023 Apr.

Abstract

Esophageal cancer (EC), as one of the leading causes of cancer-associated mortality, influences a remarkable population of subjects globally and is histologically divided into two types, comprising esophageal adenocarcinoma (EAC) and esophageal squamous cell carcinoma (ESCC). Although several therapeutic approaches are present for EC, such as radiotherapy, chemotherapy, and surgery, these options have low success with serious side effects, for example, gastrointestinal toxicity, esophagitis, and pulmonary complications. Thus, utilizing an effective tool with low side effects is urgent. Newly, mesenchymal stem cells (MSCs) have received special interest for treating diverse diseases, such as cancer. Among different sources of MSCs, human umbilical cord MSCs have notable benefits, and reports expressed that they may be effective in EC treatment. For this purpose, in this review study, we aimed to summarize evidence regarding the effects of human umbilical cord MSCs on EC with a mechanistic insight.

Keywords: esophageal cancer; mesenchymal stem cells; umbilical cord.

PubMed Disclaimer

References

REFERENCES

    1. Abnet, C. C., Arnold, M., & Wei, W. Q. (2018). Epidemiology of esophageal squamous cell carcinoma. Gastroenterology, 154(2), 360-373. https://doi.org/10.1053/j.gastro.2017.08.023
    1. ArefNezhad, R., Motedayyen, H., & Mohammadi, A. (2021). Therapeutic aspects of mesenchymal stem cell-based cell therapy with a focus on human amniotic epithelial cells in multiple sclerosis: A mechanistic review. International Journal of Stem Cells, 14(3), 241-251. https://doi.org/10.15283/ijsc21032
    1. Asakage, T., Yokoyama, A., Haneda, T., Yamazaki, M., Muto, M., Yokoyama, T., Kato, H., Igaki, H., Tsujinaka, T., Kumagai, Y., Yokoyama, M., Omori, T., & Watanabe, H. (2006). Genetic polymorphisms of alcohol and aldehyde dehydrogenases, and drinking, smoking and diet in Japanese men with oral and pharyngeal squamous cell carcinoma. Carcinogenesis, 28(4), 865-874. https://doi.org/10.1093/carcin/bgl206
    1. Baba, Y., Iwatsuki, M., Yoshida, N., Watanabe, M., & Baba, H. (2017). Review of the gut microbiome and esophageal cancer: Pathogenesis and potential clinical implications. Annals of Gastroenterological Surgery, 1(2), 99-104. https://doi.org/10.1002/ags3.12014
    1. Bansal, A., Gupta, V., & Wang, K. (2016). MicroRNA expression signatures during malignant progression from Barrett's esophagus. Journal of Cellular Biochemistry, 117(6), 1288-1295. https://doi.org/10.1002/jcb.25497

MeSH terms

LinkOut - more resources